AUTL - Autolus Therapeutics announces participation in upcoming conferences | Benzinga
LONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces its participation in three upcoming conferences in November.
Truist Securities BioPharma Symposium
Panel: Considerations for an Oncology Company's Autoimmune Side Hustle
Date and time: 9 November 2023, 11:40am ET / 16:40pm GMT
Location: New York, USA
Presenter: Dr Christian Itin, Chief Executive Officer, Autolus Therapeutics
Jefferies London Healthcare Conference
Fireside Chat
Date and time: 16 November 2023, 4:00am ET ...